Clinical Trial Update: 3BNC117-LS and 10-1074-LS in Viremic HIV-infected Individuals [Phase 1]

View source ↗

Summary

Phase 1 trial update for 3BNC117-LS and 10-1074-LS in viremic HIV-infected individuals has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• 10-1074-LS (10-1074-LS)
• 3BNC117-LS (3BNC117-LS)

Snippet

Sponsor: Rockefeller University | Conditions: Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED | Results posted: 2023-06-26